Clinical Trial Update: Aβ PET and Tau PET Imaging in the Diagnosis and Progression Assessment of Alzheimer's Disease [NA]

View source ↗

Summary

A clinical trial at Xijing Hospital evaluating Aβ PET and Tau PET imaging for diagnosing and monitoring progression of Alzheimer's disease, not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Xijing Hospital | Conditions: Alzheimer Disease (AD), Cognitive Dysfunction, Cognitive Disorder | NA | Status: NOT_YET_RECRUITING